Thursday, November 14, 2024
HomeTagsCzech

Czech

Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate’s Global Phase II Clinical Trial in Treating Parkinson’s Disease

On January 13, 2022, Green Valley (Shanghai) Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics